Is GILD up or down today?
GILD is down 1.68% today, last at 167.47. This stock moved -1.68% versus the prior close.
GILD · Gilead Sciences
GILD (Gilead Sciences) is trading at 167.47, down 1.68% on the session. GILD sits at the 87% mark of its 52-week range, carries a 14-day RSI of 67, and trades above its 50-day average. Over the past month it is up 15.79%.
Leading the coverage: “BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo” (Yahoo, 2h ago).
GILD trades on a trailing P/E of 24.6 and is running 17.78% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
GILD is down 1.68% today, last at 167.47. This stock moved -1.68% versus the prior close.
Leading the coverage: “BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo” (Yahoo, 2h ago). Dominant story: BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo (1 source, neutral) RSI is 67 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo
Dr. Reddy's granted FDA nod for first generic targeting Gilead’s Yeztugo
Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD) - MarketBeat
Gilead Sciences Stock: Analyst Estimates & Ratings
Gilead Sciences Stock: Analyst Estimates & Ratings - Barchart.com